Feasibility Trial of an eHealth Intervention for Health-Related Quality of Life: Implications for Managing Patients with Chronic Pain during the COVID-19 Pandemic

John C Licciardone, Vishruti Pandya, John C Licciardone, Vishruti Pandya

Abstract

Purpose: This study was conducted to determine the feasibility of providing an eHealth intervention for health-related quality of life (HRQOL) to facilitate patient self-management.

Methods: A randomized controlled trial was conducted from 2019-2020 within the Pain Registry for Epidemiological, Clinical, and Interventional Studies and Innovation. Eligible patients included those with chronic low back pain and a SPADE (sleep disturbance, pain interference with activities, anxiety, depression, and low energy/fatigue) cluster score ≥ 55 based on the relevant scales from the Patient-Reported Outcomes Measurement Information System instrument with 29 items (PROMIS-29). Patients were randomized to the eHealth treatment group, which received a tailored HRQOL report and interpretation guide, or to a wait-list control group. The primary outcome was change in the SPADE cluster score, including its five component scales, over 3 months. Secondary outcomes were changes in low back pain intensity and back-related disability. Treatment effects were measured using the standardized mean difference (SMD) in change scores between groups. The eHealth intervention was also assessed by a survey of the experimental treatment group 1 month following randomization.

Results: A total of 102 patients were randomized, including 52 in the eHealth treatment group and 50 in the wait-list control group, and 100 (98%) completed the trial. A majority of patients agreed that the HRQOL report was easy to understand (86%), provided new information (79%), and took actions to read or learn more about self-management approaches to improve their HRQOL (77%). Although the eHealth intervention met the criteria for a small treatment effect in improving the overall SPADE cluster score (SMD = 0.24; p= 0.23) and anxiety (SMD = 0.24; p = 0.23), and for a small-to-medium treatment effect in improving depression (SMD = 0.37; p = 0.06) and back-related disability (SMD = 0.36; p = 0.07), none of these results achieved statistical significance because of limited sample size.

Conclusion: Given the feasibility of rapid online deployment, low cost, and low risk of adverse events, this eHealth intervention for HRQOL may be useful for patients with chronic pain during the COVID-19 pandemic.

Keywords: COVID-19; back-related disability; chronic low back pain; eHealth; health-related quality of life; low back pain intensity; randomized controlled trial.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
CONSORT diagram showing patient flow through the trial. SPADE denotes sleep disturbance, pain interference with activities, anxiety, depression, low energy/fatigue.

References

    1. The White House Proclamation on Declaring a National Emergency Concerning the Novel Coronavirus Disease (COVID-19) Outbreak. [(accessed on 10 August 2020)]; Available online: .
    1. Dahlhamer J.M., Lucas J., Zelaya C., Nahin R., Mackey S., DeBar L., Kerns R., Von Korff M., Porter L., Helmick C. Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults—United States, 2016. Morb. Mortal. Wkly. Rep. 2018;67:1001–1006. doi: 10.15585/mmwr.mm6736a2.
    1. Eccleston C., Blyth F.M., Dear B.F., Fisher E.A., Keefe F.J., Lynch M.E., Palermo T.M., Reid M.C., Williams A.C.D.C. Managing patients with chronic pain during the COVID-19 outbreak. Pain. 2020;161:889–893. doi: 10.1097/j.pain.0000000000001885.
    1. World Health Organization eHealth. [(accessed on 10 August 2020)]; Available online:
    1. Gatchel R.J., Reuben D.B., Dagenais S., Turk D.C., Chou R., Hershey A.D., Hicks G.E., Licciardone J.C., Horn S.D. Research Agenda for the Prevention of Pain and Its Impact: Report of the Work Group on the Prevention of Acute and Chronic Pain of the Federal Pain Research Strategy. J. Pain. 2018;19:837–851. doi: 10.1016/j.jpain.2018.02.015.
    1. Interagency Pain Research Coordinating Committee Members Announced. J. Investig. Med. 2012;60:761–765. doi: 10.2310/JIM.0b013e3182554d7c.
    1. Institute of Medicine . Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. The National Academies Press; Washington, DC, USA: 2011.
    1. Interagency Pain Research Coordinating Committee National Pain Strategy: A Comprehensive Population Health-Level Strategy for Pain. US Department of Health and Human Services, National Institutes of Health. [(accessed on 10 August 2020)]; Available online: .
    1. Northwestern University PROMIS Adult Profile Instruments. [(accessed on 29 September 2020)]; Available online: .
    1. Deyo R.A., Dworkin S.F., Amtmann D., Andersson G., Borenstein D., Carragee E., Carrino J., Chou R., Cook K., Delitto A., et al. Report of the NIH Task Force on Research Standards for Chronic Low Back Pain. Phys. Ther. 2015;95:e1–e18. doi: 10.2522/ptj.2015.95.2.e1.
    1. Davis L.L., Kroenke K., Monahan P., Kean J., Stump T.E. The SPADE Symptom Cluster in Primary Care Patients With Chronic Pain. Clin. J. Pain. 2016;32:388–393. doi: 10.1097/AJP.0000000000000286.
    1. Gliklich R.E., Dreyer N.A. Registries for Evaluating Patient Outcomes: A User’s Guide. 2nd ed. Agency for Healthcare Research and Quality; Rockville, MD, USA: 2020. [(accessed on 29 September 2020)]. Available online:
    1. Licciardone J.C., Gatchel R.J., Phillips N., Aryal S. The Pain Registry for Epidemiological, Clinical, and Interventional Studies and Innovation (PRECISION): Registry overview and protocol for a propensity score-matched study of opioid prescribing in patients with low back pain. J. Pain Res. 2018;11:1751–1760. doi: 10.2147/JPR.S169275.
    1. Roland M., Morris R. A Study of the Natural History of Back Pain. Spine. 1983;8:141–144. doi: 10.1097/00007632-198303000-00004.
    1. Dean A.G., Sullivan K.M., Soe M.M. OpenEpi: Open Source Epidemiologic Statistics for Public Health. [(accessed on 10 August 2020)]; Available online: .
    1. McGough J.J., Faraone S.V. Estimating the size of treatment effects: Moving beyond p values. Psychiatry (Edgmont) 2009;6:21–29.
    1. Ballantyne J.C., Sullivan M.D. Intensity of Chronic Pain—The Wrong Metric? New Engl. J. Med. 2015;373:2098–2099. doi: 10.1056/NEJMp1507136.
    1. Sullivan M.D., Ballantyne J.C. Must we reduce pain intensity to treat chronic pain? Pain. 2016;157:65–69. doi: 10.1097/j.pain.0000000000000336.
    1. Dowell D., Haegerich T.M., Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016. Recomm. Rep. 2016;65:1–49. doi: 10.15585/mmwr.rr6501e1.
    1. Qaseem A., Wilt T.J., McLean R.M., Forciea M.A. Clinical Guidelines Committee of the American College of Physicians Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians. Ann. Intern. Med. 2017;166:514–530. doi: 10.7326/M16-2367.
    1. Furlan A.D., Pennick V., Bombardier C., Van Tulder M. 2009 Updated Method Guidelines for Systematic Reviews in the Cochrane Back Review Group. Spine. 2009;34:1929–1941. doi: 10.1097/BRS.0b013e3181b1c99f.
    1. Chung J.W., Zeng Y., Wong T.K. Drug therapy for the treatment of chronic nonspecific low back pain: Systematic review and meta-analysis. Pain Phys. 2013;16:E685–E704.
    1. Licciardone J.C. Demographic Characteristics Associated with Utilization of Noninvasive Treatments for Chronic Low back Pain and Related Clinical Outcomes during the COVID-19 Pandemic in the United States. [(accessed on 29 September 2020)];J. Am. Board. Fam. Med. 2020 Available online: .
    1. El-Tallawy S.N., Nalamasu R., Pergolizzi J.V., Gharibo C. Pain Management During the COVID-19 Pandemic. Pain Ther. 2020:1–14. doi: 10.1007/s40122-020-00190-4.
    1. Shanthanna H., Strand N.H., Provenzano D.A., Lobo C.A., Eldabe S., Bhatia A., Wegener J., Curtis K., Cohen S.P., Narouze S. Caring for patients with pain during the COVID-19 pandemic: Consensus recommendations from an international expert panel. Anaesthesia. 2020;75:935–944. doi: 10.1111/anae.15076.
    1. Cohen S.P., Baber Z.B., Buvanendran A., McLean L.T.C.B.C., Chen Y., Hooten W.M., Laker S.R., Wasan W.A.D., Kennedy D.J., Sandbrink F., et al. Pain Management Best Practices from Multispecialty Organizations during the COVID-19 Pandemic and Public Health Crises. Pain Med. 2020;21:1331–1346. doi: 10.1093/pm/pnaa127.
    1. Javed S., Hung J., Huh B.K. Impact of COVID-19 on chronic pain patients: A pain physician’s perspective. Pain Manag. 2020;10:275–277. doi: 10.2217/pmt-2020-0035.
    1. Kroenke K., Talib T.L., Stump T.E., Kean J., Haggstrom D.A., DeChant P., Lake K.R., Stout M., Monahan P.O. Incorporating PROMIS Symptom Measures into Primary Care Practice—A Randomized Clinical Trial. J. Gen. Intern. Med. 2018;33:1245–1252. doi: 10.1007/s11606-018-4391-0.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj